Aortyx
Company Details
Status: Private
Employees: 1-10
Location:
carrer la vinya, teià, catalunya, spain
Type:
sample
Technology:
About: Aortyx is a medical device startup based in Barcelona, founded in 2018 by researchers from the Institut Químic de Sarrià and Hospital Clínic de Barcelona. The company aims to improve aortic disease management through innovative biomaterials and endovascular technologies, addressing critical needs in vascular repair.
Aortyx specializes in biomimetic, bioresorbable endovascular patches that are deployed using a proprietary aortic catheter system. These patches promote tissue regeneration by encouraging cell migration and proliferation in damaged aortic walls, while mimicking the biomechanical environment of the aorta. The technology is designed to resorb over time, reducing the risks associated with permanent implants and targeting conditions like aortic dissection.
With a team of nearly 20 experts in biomaterials, vascular engineering, and aortic surgery, Aortyx has secured significant funding to advance its preclinical development. The company positions itself as a pioneer in bioresorbable solutions for aortic diseases, focusing on collaboration with endovascular surgeons and hospitals.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Aortyx | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.